• Skip to primary navigation
  • Skip to main content
  • Skip to footer
PanTher Therapeutics

PanTher Therapeutics

  • About Us
    • Mission
    • Team
  • Our Technology
    • Platform
    • Products
  • News
  • Careers
  • Contact
homePress Release

Press Release

Filter:

  • All
  • News
  • Press Release

October 16, 2018 News, Press Release

PanTher Therapeutics Announces Agreement with MD Anderson Cancer Center and Appointment of Senior Clinical Advisor

PanTher Therapeutics, the biotech company developing drug-delivery platforms for unresectable, locally advanced solid tumors, today announced an agreement with The University of Texas MD Anderson Cancer Center and the appointment of a new senior clinical advisor. The collaboration will support preclinical testing of PanTher’s lead product for pancreatic cancer, PTM-101, and is intended to demonstrate readiness for future human clinical trials.

Read More about PanTher Therapeutics Announces Agreement with MD Anderson Cancer Center and Appointment of Senior Clinical Advisor

June 20, 2018 Press Release

Massachusetts Life Sciences Center selects Laura Indolfi, CEO as MassNextGen Award winner

Laura Indolfi was named one of the five winners of the Massachusetts Life Sciences Center  (MLSC) Initiative for Women Entrepreneurs inaugural awards to support women in early-stage life sciences companies. Lt. Governor Karyn Polito announced the 2018 winners for the MLSC Massachusetts Next Generation Initiative (MassNextGen), a competitive program to support women entrepreneurs in early-stage life sciences companies. The public-private partnership, a five-year, $1.1 million commitment, focuses on empowering women and diversity in the next generation of life sciences entrepreneurs. Five women-led companies were selected as awardees through the MassNextGen program. Awardees represent a wide range of applications to improve human health. All five companies will receive access to a network of executive coaches for a year. 

Read More about Massachusetts Life Sciences Center selects Laura Indolfi, CEO as MassNextGen Award winner

September 20, 2016 Press Release

Bristol-Myers Squibb Awards PanTher with ‘Golden Ticket’ for LabCentral

Bristol-Myers Squibb Company and LabCentral, an innovative, shared laboratory space designed as a launch pad for life-sciences and biotech startups, today announced that PanTher is one of the winners of Bristol-Myers Squibb’s Golden Tickets for LabCentral. As a platinum sponsor of LabCentral, Bristol-Myers Squibb can select up to two innovative life-sciences and biotech startup companies per year of active sponsorship for “Golden Tickets,” which underwrite the cost of one lab bench for one year in LabCentral’s Kendall Square facility. 

Read More about Bristol-Myers Squibb Awards PanTher with ‘Golden Ticket’ for LabCentral

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2

Footer

Twitter LinkedIn

PanTher Therapeutics, Inc

Austin, TX
Watertown, MA

PanTher Therapeutics © 2022 All Rights Reserved

Terms of Use Privacy Policy Cookie Policy Accessibility Statement

logo
  • About Us
    • Mission
    • Team
  • Our Technology
    • Platform
    • Products
  • News
  • Careers
  • Contact